美国食品和药物管理局表示, 卢宾因制造问题召回了超过60万瓶的血压药物拉米普利. Lupin recalls over 600,000 bottles of blood pressure drug Ramipril due to manufacturing issues, FDA says.

由于制造问题, 药品制造商Lupin在美国召回了600,000多瓶血压药物Ramipril。 Drug manufacturer Lupin is recalling over 600,000 bottles of its blood pressure medication Ramipril in the U.S. due to manufacturing issues. 由Lupin制药公司发起的召回行动对Ramipril胶囊的影响为2.5毫克、5毫克和10毫克。 The recall, initiated by Lupin Pharmaceuticals Inc., affects Ramipril capsules in 2.5 mg, 5 mg, and 10 mg strengths. 美国食品和药品管理局(食品和药品管理局)将这一重新分类为第二类,表明潜在的暂时健康风险。 The U.S. Food and Drug Administration (FDA) categorized this recall as Class II, indicating potential temporary health risks. 此外,Reddy医生的实验室正在回忆大约3 400瓶ibuprofen 600毫克药片,原因是质量问题,被归类为第三类,对健康产生不利影响的风险较低。 Additionally, Dr. Reddy's Laboratories is recalling about 3,400 bottles of ibuprofen 600 mg tablets due to quality concerns, categorized as Class III, with low risk of adverse health effects.